Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease

NCT00928629 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca

Collaborators